National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings, 17179 [2019-08186]
Download as PDF
<![CDATA[
17179
Federal Register / Vol. 84, No. 79 / Wednesday, April 24, 2019 / Notices
ANNUALIZED BURDEN HOUR TABLE
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Grantee Leadership Staff Interview Topic Guide:
Initial.
Grantee Leadership Staff Interview Topic Guide:
Follow-up.
Key Program Staff Interview topic guide ..............
Grantee leadership staff
15
1
90/60
23
Grantee leadership staff
15
1
1
15
47
1
1
47
9
1
45/60
7
Frontline Staff Survey ...........................................
Front line staff and supervisors.
Key community stakeholders.
Frontline staff ................
117
1
30/60
59
Total ...............................................................
.......................................
........................
5
........................
151
Community Stakeholder Interview Topic Guide ...
Terry Clark,
Office of the Secretary, Asst. Paperwork
Reduction Act Reports Clearance Officer.
[FR Doc. 2019–08192 Filed 4–23–19; 8:45 am]
BILLING CODE 4150–30–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
jbell on DSK30RV082PROD with NOTICES
Number
responses per
respondent
Number of
respondents
Forms (if necessary)
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Planning Grant (R34).
Date: May 13, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, DEA/SRP RM 3G53A,
National Institutes of Health, NIAID 5601
Fishers Lane, MSC 9823, Rockville, MD
20892–9823, 301–761–7322, julio.aliberti@
nih.gov.
VerDate Sep<11>2014
17:20 Apr 23, 2019
Jkt 247001
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Application (P01).
Date: May 14, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5601
Fishers Ln., Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Julio C. Aliberti, Ph.D.,
Scientific Review Officer, Immunology
Review Branch, DEA/SRP RM 3G53A,
National Institutes of Health, NIAID 5601
Fishers Lane, MSC 9823, Rockville, MD
20892–9823, 301–761–7322, julio.aliberti@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: April 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–08186 Filed 4–23–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
PO 00000
Frm 00046
Fmt 4703
Sfmt 9990
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Examining
Diversity in Aging Research ZAG1 ZIJ–9 O1.
Date: May 30, 2019.
Time: 10:30 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20814,
(Telephone Conference Call).
Contact Person: Carmen, Moten, Ph.D.,
MPH, Scientific Review Officer, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7703, cmoten@
mail.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NIA MSTEM
ZAG1 ZIJ–9 O2.
Date: May 31, 2019.
Time: 10:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W–200, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carmen, Moten, Ph.D.,
MPH, Scientific Review Officer, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7703, cmoten@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: April 18, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–08193 Filed 4–23–19; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 84, Number 79 (Wednesday, April 24, 2019)]
[Notices]
[Page 17179]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08186]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant
(R34).
Date: May 13, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Julio C. Aliberti, Ph.D., Scientific Review
Officer, Immunology Review Branch, DEA/SRP RM 3G53A, National
Institutes of Health, NIAID 5601 Fishers Lane, MSC 9823, Rockville,
MD 20892-9823, 301-761-7322, [email protected].
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID Investigator Initiated
Program Project Application (P01).
Date: May 14, 2019.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5601 Fishers Ln.,
Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Julio C. Aliberti, Ph.D., Scientific Review
Officer, Immunology Review Branch, DEA/SRP RM 3G53A, National
Institutes of Health, NIAID 5601 Fishers Lane, MSC 9823, Rockville,
MD 20892-9823, 301-761-7322, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: April 18, 2019.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-08186 Filed 4-23-19; 8:45 am]
BILLING CODE 4140-01-P
